MRC Technology sells its melanocortin receptors programme to Pfizer Inc
The melanocortin receptors (MCRs) programme includes a set of small molecules and targets for these small molecules came from Mauro Perretti, Professor of Immunopharmacology at Queen Mary University of London (QMUL).